• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Which States are Hitting the COVID-19 Vaccine Tipping Point?

As of April 19, COVID-19 vaccine eligibility opened up to adults in all states, leaving many to wonder when supply will surpass vaccine demand. A recent brief examined when COVID-19 vaccine supply might outstrip demand in the U.S. nationally, estimating that the U.S. will reach this point within a few…

Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations? An April 2021 Update.

This analysis updates earlier work and examines the extent to which vaccination efforts through community health centers are reaching people of color using data from the federal government’s weekly Health Center COVID-19 Survey. We include data from the survey weeks of January 8 through April 2, 2021, finding that people of color made up the majority of people who received vaccinations at community health centers.

KFF COVID-19 Vaccine Monitor: What We’ve Learned

This brief summarizes key findings and themes from the COVID-19 Vaccine Monitor project that is tracking the dynamic nature of the U.S. public’s attitudes and experiences with COVID-19 vaccination, and is based on more than 11,000 interviews conducted since December 2020.

Vaccine Monitor: What We’ve Learned

With nearly all states poised to allow anyone at least 16 years old to get a COVID-19 vaccine, this week’s announcement pausing the distribution of the Johnson & Johnson vaccine to investigate a rare side effect is raising questions about whether and how it will affect the public’s eagerness to…

Vaccine Passports: What We Know and What to Consider

Around the country and in parts of the world, COVID-19 vaccination efforts continue to grow, leaving people wondering about vaccine requirements and ways to certify vaccine status. “Vaccine passports,” a paper or digital form certifying that a person has been vaccinated, have garnered increased interest in recent months, especially as…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.